Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study

Chappell CA, Scarsi KK, Kirby BJ, Suri V, Gaggar A, Bogen DL, et al. Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study. Lancet Microbe [Internet]. 2020;1(5):e200–08. https://doi.org/10.1016/s2666-5247(20)30062-8

Publication Type:

Journal Article

Authors:

Catherine A Chappell; Kimberly K Scarsi; Brian J Kirby; Vithika Suri; Anuj Gaggar; Debra L Bogen; Ingrid S Macio; Leslie A Meyn; Katherine E Bunge; Elizabeth E Krans; Sharon L Hillie

Source:

Lancet Microbe, Volume 1, Issue 5, p.e200–08 (2020)

URL:

https://doi.org/10.1016/s2666-5247(20)30062-8

Cited On:

External Third-party Web Link:

https://doi.org/10.1016/s2666-5247(20)30062-8

Export Citation:
RIS Format
Top